Cargando…
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genom...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674007/ https://www.ncbi.nlm.nih.gov/pubmed/33275900 http://dx.doi.org/10.1016/j.cell.2020.11.020 |
_version_ | 1783611433918922752 |
---|---|
author | Volz, Erik Hill, Verity McCrone, John T. Price, Anna Jorgensen, David O’Toole, Áine Southgate, Joel Johnson, Robert Jackson, Ben Nascimento, Fabricia F. Rey, Sara M. Nicholls, Samuel M. Colquhoun, Rachel M. da Silva Filipe, Ana Shepherd, James Pascall, David J. Shah, Rajiv Jesudason, Natasha Li, Kathy Jarrett, Ruth Pacchiarini, Nicole Bull, Matthew Geidelberg, Lily Siveroni, Igor Goodfellow, Ian Loman, Nicholas J. Pybus, Oliver G. Robertson, David L. Thomson, Emma C. Rambaut, Andrew Connor, Thomas R. |
author_facet | Volz, Erik Hill, Verity McCrone, John T. Price, Anna Jorgensen, David O’Toole, Áine Southgate, Joel Johnson, Robert Jackson, Ben Nascimento, Fabricia F. Rey, Sara M. Nicholls, Samuel M. Colquhoun, Rachel M. da Silva Filipe, Ana Shepherd, James Pascall, David J. Shah, Rajiv Jesudason, Natasha Li, Kathy Jarrett, Ruth Pacchiarini, Nicole Bull, Matthew Geidelberg, Lily Siveroni, Igor Goodfellow, Ian Loman, Nicholas J. Pybus, Oliver G. Robertson, David L. Thomson, Emma C. Rambaut, Andrew Connor, Thomas R. |
author_sort | Volz, Erik |
collection | PubMed |
description | Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant. |
format | Online Article Text |
id | pubmed-7674007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-76740072020-11-19 Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity Volz, Erik Hill, Verity McCrone, John T. Price, Anna Jorgensen, David O’Toole, Áine Southgate, Joel Johnson, Robert Jackson, Ben Nascimento, Fabricia F. Rey, Sara M. Nicholls, Samuel M. Colquhoun, Rachel M. da Silva Filipe, Ana Shepherd, James Pascall, David J. Shah, Rajiv Jesudason, Natasha Li, Kathy Jarrett, Ruth Pacchiarini, Nicole Bull, Matthew Geidelberg, Lily Siveroni, Igor Goodfellow, Ian Loman, Nicholas J. Pybus, Oliver G. Robertson, David L. Thomson, Emma C. Rambaut, Andrew Connor, Thomas R. Cell Article Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant. Cell Press 2021-01-07 /pmc/articles/PMC7674007/ /pubmed/33275900 http://dx.doi.org/10.1016/j.cell.2020.11.020 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Volz, Erik Hill, Verity McCrone, John T. Price, Anna Jorgensen, David O’Toole, Áine Southgate, Joel Johnson, Robert Jackson, Ben Nascimento, Fabricia F. Rey, Sara M. Nicholls, Samuel M. Colquhoun, Rachel M. da Silva Filipe, Ana Shepherd, James Pascall, David J. Shah, Rajiv Jesudason, Natasha Li, Kathy Jarrett, Ruth Pacchiarini, Nicole Bull, Matthew Geidelberg, Lily Siveroni, Igor Goodfellow, Ian Loman, Nicholas J. Pybus, Oliver G. Robertson, David L. Thomson, Emma C. Rambaut, Andrew Connor, Thomas R. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
title | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
title_full | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
title_fullStr | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
title_full_unstemmed | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
title_short | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
title_sort | evaluating the effects of sars-cov-2 spike mutation d614g on transmissibility and pathogenicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674007/ https://www.ncbi.nlm.nih.gov/pubmed/33275900 http://dx.doi.org/10.1016/j.cell.2020.11.020 |
work_keys_str_mv | AT volzerik evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT hillverity evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT mccronejohnt evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT priceanna evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT jorgensendavid evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT otooleaine evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT southgatejoel evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT johnsonrobert evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT jacksonben evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT nascimentofabriciaf evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT reysaram evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT nichollssamuelm evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT colquhounrachelm evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT dasilvafilipeana evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT shepherdjames evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT pascalldavidj evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT shahrajiv evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT jesudasonnatasha evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT likathy evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT jarrettruth evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT pacchiarininicole evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT bullmatthew evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT geidelberglily evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT siveroniigor evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT goodfellowian evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT lomannicholasj evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT pybusoliverg evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT robertsondavidl evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT thomsonemmac evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT rambautandrew evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity AT connorthomasr evaluatingtheeffectsofsarscov2spikemutationd614gontransmissibilityandpathogenicity |